In the seemingly endless legal slugfest between Jack Nicklaus (the golfer) and the Nicklaus Companies, LLC (his former ...

All The Harborside residents affected by the pending closure of its nursing home, assisted living and dementia care unit have ...

NVIDIA also recently accepted Stereotaxis into its NVIDIA Connect program, which supports member companies with NVIDIA’s software development resources, industry-leading frameworks and software ...

STOCKHOLM, March 19, 2025 /PRNewswire/ -- Noxit has been accepted into the Stockholm School of Economics' incubator, SSE Business Lab— one of Europe's most prominent startup environments.

LONDON--(BUSINESS WIRE)--Perfect Moment Ltd. (NYSE American: PMNT), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, has received ...

MANILA, Philippines — Rising temperatures in the country have prompted the Department of Health (DOH) to advise the public to avoid drinking coffee and alcoholic drinks, but instead drink water ...

Detecting metal in poultry products is a major challenge due to their high conductivity, often resulting in false rejects and product loss. As a best practice example, Plukon has implemented the metal ...

MP Natalie Fleet warns rape threats 'are an accepted part of the job" for women MPs 'I am the 690th woman MP so Rape Crisis estimates that a quarter of women have been raped or sexually assaulted.

The Department of Health (DOH) is continuously monitoring hand, foot, and mouth disease (HFMD) cases after recording over 7,500 cases from January 1 to February 22, 2025.

This according to Department of Health (DOH) Assistant Secretary Dr. Albert Francis Domingo, who, in response to questions from Associate Justice Antonio Kho Jr. on whether the government should ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals ... announced that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics Licensing Application (BLA) for ...

Amneal Pharmaceuticals (AMRX) “announced that the FDA has accepted for review its Biologics Licensing Application for two proposed denosumab biosimilars referencing Prolia and XGEVA. mAbxience ...